Amazon cover image
Image from Amazon.com

Global pharmaceutical policy : [Book] : ensuring medicines for tomorrow's world / Frederick M. Abbott, Graham Dukes.

By: Contributor(s): Material type: TextTextPublication details: Northampton, MA : Northampton, MA : Edward Elgar, c2009.Description: x, 308 pages. : ill. ; 25 cmISBN:
  • 9781848440906 (hbk.)
  • 1848440901 (hbk.)
Subject(s): DDC classification:
  • 344.04233 22
LOC classification:
  • K3636 .A93 2009
Other classification:
  • 344.04233
Contents:
The challenges we face -- Promoting innovation : patents, subsidies, prizes and prices -- Policies on innovation: past, present, and future -- The global regulatory environment : quality, safety, and efficacy -- Medicines for the developing world -- The use of medicines : education, information, and persuasion -- Regulation and the role of the courts -- Specialized policy areas : vaccines, biologicals, and blood products : alternative and traditional medicines : self-medication : counterfeit medicines -- The rich, the poor, and the neglected -- Global and regional policies : the way ahead.
Summary: Pharmaceuticals play a central role in health care throughout the world. The pharmaceutical industry is beset with difficulties as increasing research and development expenditure yields fewer new treatments. Public and private budgets strain under the weight of high prices and limited access. The world's poor see little effort to address diseases prevalent in less affluent societies, while the world's wealthy are overusing prescription drugs, risking their health and wasting resources. As the global economic crisis exacerbates pressure on health care budgets, a new presidential administration in Washington, DC has committed to broad health care reform. These circumstances form the backdrop for this extraordinarily timely examination of the global system for the development, production, distribution and use of medicines. The authors are acknowledged experts in the fields of pharmaceutical law and policy, with many years experience advising governments, multilateral organizations and policy-makers on issues involving innovation, access and use of medicines. Supported by a team of independent scientists, doctors and lawyers, they take an insightful look at the issues surrounding global regulation of the pharmaceutical sector, and offer pragmatic suggestions for reform. This book will be of interest to government policy-makers, members of industry, healthcare professionals, teachers, students and lawyers in the fields of public health, intellectual property and international trade.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Status Date due Barcode Item holds
Books Books Junaid Zaidi Library, COMSATS University Islamabad 344.04233 ABB-G (Browse shelf(Opens below)) Available 52446
Total holds: 0

Includes bibliographical references and index.

The challenges we face -- Promoting innovation : patents, subsidies, prizes and prices -- Policies on innovation: past, present, and future -- The global regulatory environment : quality, safety, and efficacy -- Medicines for the developing world -- The use of medicines : education, information, and persuasion -- Regulation and the role of the courts -- Specialized policy areas : vaccines, biologicals, and blood products : alternative and traditional medicines : self-medication : counterfeit medicines -- The rich, the poor, and the neglected -- Global and regional policies : the way ahead.

Pharmaceuticals play a central role in health care throughout the world. The pharmaceutical industry is beset with difficulties as increasing research and development expenditure yields fewer new treatments. Public and private budgets strain under the weight of high prices and limited access. The world's poor see little effort to address diseases prevalent in less affluent societies, while the world's wealthy are overusing prescription drugs, risking their health and wasting resources. As the global economic crisis exacerbates pressure on health care budgets, a new presidential administration in Washington, DC has committed to broad health care reform. These circumstances form the backdrop for this extraordinarily timely examination of the global system for the development, production, distribution and use of medicines. The authors are acknowledged experts in the fields of pharmaceutical law and policy, with many years experience advising governments, multilateral organizations and policy-makers on issues involving innovation, access and use of medicines. Supported by a team of independent scientists, doctors and lawyers, they take an insightful look at the issues surrounding global regulation of the pharmaceutical sector, and offer pragmatic suggestions for reform. This book will be of interest to government policy-makers, members of industry, healthcare professionals, teachers, students and lawyers in the fields of public health, intellectual property and international trade.

All.

There are no comments on this title.

to post a comment.